君实生物在科创板上市

007.html" title="ds">ds-13240.html" title="sf">sform: none; text-indent: 0px; letter-spacing: normal; font-family: arial; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">      7月15日，君实生物在科创板正式挂牌交易，开盘报216元，较发行定价上涨289.2%，最新总市值为1882.04亿元。根据最新注册稿，君实生物此次科创板上市，采用第五套上市标准，保荐机构为中国国际金融股份有限公司，募集资金将主要用于创新药的研发项目，以及君实生物科技产业化临港项目。

007.html" title="ds">ds-13240.html" title="sf">sform: none; text-indent: 0px; letter-spacing: normal; font-family: arial; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">                                                                                 007.html" title="ds">ds-11450.html" title="23">23784810.png" alt="2.png" src="http://118.190.104.172:8005//uploa007.html" title="ds">ds/editor/20200715/15947842007.html" title="ds">ds-11450.html" title="23">23784810.png"/>

007.html" title="ds">ds-13240.html" title="sf">sform: none; text-indent: 0px; letter-spacing: normal; font-family: arial; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">      007.html" title="ds">ds-13240.html" title="sf">sform: none; text-indent: 0px; letter-spacing: normal; font-family: arial; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255, 007.html" title="ds">ds-11438.html" title="25">255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">君实生物是一家创新驱动型生物制药公司，主要从事创新药物的发现和开发，以及在全球范围内的临床研发及商业化。该公司拥有国内首个获批上市的国产抗PD-1单克隆抗体，该产品也是君实生物目前唯一获批上市的药品。007.html" title="ds">ds-110.html" title="55">558.html" title="32">32px; font-family: arial;">产品咨询0, 1007.html" title="ds">ds-4587.html" title="12">12, 192); text-indent: 007.html" title="ds">ds-110.html" title="55">558.html" title="32">32px; font-family: arial; white-space: normal;" href="http://www.xiyashiji.com/" target="_self">西亚试剂